Point of Care Molecular Diagnostics Market

Published on 2025-11-04
Report Code: 1509
170-350 pages

Point of Care Molecular Diagnostics Market: By Product and Service (Assays & Kits, Instruments & Analyzers, Software & Services), By Technology (RT-PCR, INAAT, Other Technologies), By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infections, Cancer, Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians, Offices, Hospitals & ICUs, Research Institutes, Other End Users) And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031

Buy Now

Add to cart

Table Of Content

1 Executive Summary
2 Global Point of Care Molecular Diagnostics Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 Average Pricing Analysis
5 Macro-Economic Indicators
6 Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8 Recent Development, Policies & Regulatory Landscape
9 Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 Global Point of Care Molecular Diagnostics Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 Global Point of Care Molecular Diagnostics Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 Global Point of Care Molecular Diagnostics Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product & Service: Market Share (2020-2031F)
12.2.1. Assays & Kits, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Instruments & Analyzers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Software & Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Technology: Market Share (2020-2031F)
12.3.1. RT-PCR, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. INAAT, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Other Technologies, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By Application: Market Share (2020-2031F)
12.4.1. Respiratory Diseases, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Sexually Transmitted Diseases, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Hospital-acquired Infections, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Cancer, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Hepatitis, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.6. Gastrointestinal Disorders, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.7. Other Applications, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.5. By End User: Market Share (2020-2031F)
12.5.1. Physicians’ Offices, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.5.2. Hospitals & ICUs, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.5.3. Research Institutes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.5.4. Other End Users, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 Company Profile
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Bayer AG
13.3. BioMerieux SA
13.4. Bio-Rad Laboratories, Inc.
13.5. Danaher Corporation
13.6. F. Hoffmann-La Roche Ltd.
13.7. Nova Biomedical
13.8. OraSure Technologies, Inc.
13.9. Qiagen Gmbh
13.10. Sekisui Medical Co., Ltd.
13.11. Zoetis Inc.
13.12. Other Prominent Players
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.